Novo Nordisk’s diabetes drug Ozempic may lower the risk of opioid overdoses, study says
CNBC: Rong Xu, professor at the School of Medicine, said that Novo Nordisk’s diabetes drug Ozempic, containing semaglutide, may reduce opioid overdose risk. She emphasized the drug’s potential as an alternative treatment for opioid use disorder, but noted the need for further research to confirm its effectiveness.
